KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Short-term Investments (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Short-term Investments for 13 consecutive years, with $9.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 98.13% to $9.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.0 million, a 98.13% decrease, with the full-year FY2025 number at $9.0 million, down 98.13% from a year prior.
  • Short-term Investments was $9.0 million for Q4 2025 at Halozyme Therapeutics, down from $282.3 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $668.3 million in Q1 2022 to a low of $9.0 million in Q4 2025.
  • A 5-year average of $320.4 million and a median of $282.3 million in 2025 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: skyrocketed 182.42% in 2021, then tumbled 98.13% in 2025.
  • Halozyme Therapeutics' Short-term Investments stood at $622.2 million in 2021, then plummeted by 79.33% to $128.6 million in 2022, then skyrocketed by 69.23% to $217.6 million in 2023, then soared by 120.66% to $480.2 million in 2024, then crashed by 98.13% to $9.0 million in 2025.
  • Per Business Quant, the three most recent readings for HALO's Short-term Investments are $9.0 million (Q4 2025), $282.3 million (Q3 2025), and $571.6 million (Q1 2025).